Simcere Pharmaceutical Group Limited (2096.HK)

HKD 8.99

(2.63%)

Revenue Summary of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited's latest annual revenue in 2023 was 6.6 Billion CNY , up 4.57% from previous year.
Simcere Pharmaceutical Group Limited's latest quarterly revenue in 2024 Q2 was 1.55 Billion CNY , down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported a annual revenue of 6.31 Billion CNY in annual revenue 2022, up 26.39% from previous year.
Simcere Pharmaceutical Group Limited reported a annual revenue of 4.99 Billion CNY in annual revenue 2021, up 10.89% from previous year.
Simcere Pharmaceutical Group Limited reported a quarterly revenue of 1.55 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported a quarterly revenue of 1.61 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Simcere Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Revenue of Simcere Pharmaceutical Group Limited (2023 - 2012)

Year	Revenue	Revenue Growth
2023	6.6 Billion CNY	4.57%
2022	6.31 Billion CNY	26.39%
2021	4.99 Billion CNY	10.89%
2020	4.5 Billion CNY	-10.48%
2019	5.03 Billion CNY	11.57%
2018	4.51 Billion CNY	16.71%
2017	3.86 Billion CNY	0.0%
2012	2.08 Billion CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	1.55 Billion CNY	-3.56%
2024 Q2	1.55 Billion CNY	0.0%
2023 Q4	1.61 Billion CNY	0.0%
2023 FY	6.6 Billion CNY	4.57%
2023 Q1	1.68 Billion CNY	-6.76%
2023 Q2	1.68 Billion CNY	0.0%
2023 Q3	1.61 Billion CNY	-4.46%
2022 Q1	1.34 Billion CNY	-6.25%
2022 FY	6.31 Billion CNY	26.39%
2022 Q4	1.81 Billion CNY	0.0%
2022 Q3	1.81 Billion CNY	34.26%
2022 Q2	1.34 Billion CNY	0.0%
2021 Q3	1.43 Billion CNY	35.84%
2021 FY	4.99 Billion CNY	10.89%
2021 Q1	1.06 Billion CNY	-17.93%
2021 Q2	1.06 Billion CNY	0.0%
2021 Q4	1.43 Billion CNY	0.0%
2020 Q4	1.29 Billion CNY	0.0%
2020 FY	4.5 Billion CNY	-10.48%
2020 Q1	962.7 Million CNY	-26.58%
2020 Q2	962.7 Million CNY	0.0%
2020 Q3	1.29 Billion CNY	34.17%
2019 Q2	1.2 Billion CNY	0.0%
2019 Q1	1.2 Billion CNY	0.0%
2019 Q4	1.31 Billion CNY	0.0%
2019 FY	5.03 Billion CNY	11.57%
2019 Q3	1.31 Billion CNY	8.64%
2018 FY	4.51 Billion CNY	16.71%
2017 FY	3.86 Billion CNY	0.0%
2013 Q1	528.72 Million CNY	-2.11%
2013 Q2	482.99 Million CNY	-8.65%
2013 Q3	421.3 Million CNY	-12.77%
2012 Q1	600.82 Million CNY	0.0%
2012 Q2	645.21 Million CNY	7.39%
2012 Q3	504.71 Million CNY	-21.78%
2012 Q4	540.14 Million CNY	7.02%
2012 FY	2.08 Billion CNY	0.0%

Peer Revenue Comparison of Simcere Pharmaceutical Group Limited

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-1263.227%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	-24.143%